Nicola Crosetto. Photo: Stefan Zimmerman
Researchers at Karolinska Institutet have developed a technology for cost-effective surveillance of the global spread of new SARS-CoV-2 variants. The technique is presented in the scientific journal Nature Communications.
Since the onset of the pandemic, thousands of viral genomes have been sequenced to reconstruct the evolution and global spread of the coronavirus. This is important for the identification of particularly concerning variants that are more contagious, pathogenic, or resistant to the existing vaccines.
For global surveillance of the SARS-CoV-2 genome, it is crucial to sequence and analyse many samples in a cost-effective way. Therefore, researchers in the Bienko-Crosetto laboratory at Karolinska Institutet and Science for Life Laboratory (SciLifeLab) in Sweden have developed a new method, named COVseq, that can be used for surveillance of the viral genome on a massive scale at a low cost.
Adapted a previous method
First, many copies of the viral genome are created using so-called multiplex PCR (polymerase chain reaction). The samples are then labelled and pooled together in the same sequencing library, using a previous method developed in the Bienko-Crosetto laboratory and now adapted for SARS-CoV-2 analysis.
“By performing reactions in very small volumes and pooling together hundreds of samples into the same sequencing library, we can sequence potentially thousands of viral genomes per week at a cost of less than 15 dollars per sample,” says Ning Zhang, who previously worked as a postdoctoral researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet and is co-first author together with PhD students Michele Simonetti and Luuk Harbers active at the same department.
Comparative analyses of 29 SARS-CoV-2 positive samples revealed that COVseq had a similar ability as the standard method to identify small changes in the genome. Analyses of 245 additional samples showed that COVseq also had a high ability to detect emergent coronavirus variants of potential concern. The key advantage of COVseq over existing methods is cost-effectiveness.
Could be used by public health agencies
“Our inexpensive method could immediately be used for SARS-CoV-2 genomic surveillance by public health agencies and could also be easily adapted to other RNA viruses, such as influenza and dengue viruses,” says Nicola Crosetto, senior researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, and last author of the paper.
Original Article: Low-cost method for finding new coronavirus variants
More from: Karolinska Institutet
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
SARS-CoV-2 variants
- Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants
Study: Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism. Most previously known anti-SARS-CoV-2 antibodies block receptor-binding-domain (RBD)-binding to the host ...
- Researchers examine the infectious periods in vaccinated individuals with SARS-CoV-2, omicron and delta variants
In January 2022, the U.S. shifted its guidelines to recommend isolation of five days from COVID-19 symptom onset, followed by an additional five days of mask wearing. However, the progression of the ...
- BBU researchers examine the infectious periods in vaccinated individuals with SARS-CoV-2, omicron and delta variants
Researchers from Boston University School of Medicine (BUSM) collected daily anterior nasal swabs for at least 10 days from a group of college students and staff for reverse transcription-polymerase ...
- Antigenic differences between early SARS-CoV-2 variants
Researchers used antigenic cartography to quantify and visualize antigenic differences between multiple SARS‐CoV‐2 variants.
- SARS-CoV-2 Variants Develop in Chronic, Immunosuppressed Patients
Immunocompromised patients can develop chronic coronavirus infections, leading to highly mutated variants that bear multiple antibody-resistant mutations.
Go deeper with Google Headlines on:
SARS-CoV-2 variants
Go deeper with Bing News on:
SARS-CoV-2 genomic surveillance
- Monkeypox becoming pandemic is less likely: Researchers
The emergence of monkeypox disease in non-endemic areas is a reminder that infectious diseases and pathogens are not restricted by the geographical borders, the group of researchers said.
- Monkeypox’ likelihood of becoming pandemic low: Researchers
The group of public health and infectious diseases researchers said that the emergence of monkeypox disease in non-endemic areas is a reminder that infectious diseases and pathogens are not restricted ...
- Possibility of monkeypox becoming a pandemic is low: Researchers
The group of public health and infectious diseases researchers said that the emergence of monkeypox disease in non-endemic areas is a reminder that infectious diseases and pathogens are not restricted ...
- This AI Tool Could Predict the Next Coronavirus Variant
The model, which uses machine learning to track the fitness of different viral strains, accurately predicted the rise of Omicron BA.2 and Alpha ...
- Recombinant SARS-CoV-2 harboring double reporters for COVID-19 surveillance
In a recent article posted to the bioRxiv* preprint server, researchers at Texas Biomedical Research Institute, Georgia State University, and the University of Alabama at Birmingham developed a ...